HEADER TRANSFERASE 17-JUL-00 1FBZ
TITLE STRUCTURE-BASED DESIGN OF A NOVEL, OSTEOCLAST-SELECTIVE, NONPEPTIDE
TITLE 2 SRC SH2 INHIBITOR WITH IN VIVO ANTI-RESORPTIVE ACTIVITY
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: SH2 DOMAIN;
COMPND 5 EC: 2.7.1.112;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS SH2 DOMAIN, NONPEPTIDE INHIBITOR, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR W.SHAKESPEARE,M.YANG,R.BOHACEK,F.CERASOLI,K.STEBBIS,R.SUNDARAMOORTHI,
AUTHOR 2 C.VU,S.PRADEEPAN,C.METCALF,C.HARALDSON,T.MERRY,D.DALGARNO,S.NARULA,
AUTHOR 3 M.HATADA,X.LU,M.R.VAN SCHRAVENDIJK,S.ADAMS,S.VIOLETTE,J.SMITH,
AUTHOR 4 W.GUAN,C.BARTLETT,J.HERSON,J.IULIUCCI,M.WEIGELE,T.SAWYER
REVDAT 4 07-FEB-24 1FBZ 1 REMARK SEQADV
REVDAT 3 24-FEB-09 1FBZ 1 VERSN
REVDAT 2 31-MAY-05 1FBZ 1 JRNL
REVDAT 1 23-AUG-00 1FBZ 0
JRNL AUTH W.SHAKESPEARE,M.YANG,R.BOHACEK,F.CERASOLI,K.STEBBINS,
JRNL AUTH 2 R.SUNDARAMOORTHI,M.AZIMIOARA,C.VU,S.PRADEEPAN,C.METCALF,
JRNL AUTH 3 C.HARALDSON,T.MERRY,D.DALGARNO,S.NARULA,M.HATADA,X.LU,
JRNL AUTH 4 M.R.VAN SCHRAVENDIJK,S.ADAMS,S.VIOLETTE,J.SMITH,W.GUAN,
JRNL AUTH 5 C.BARTLETT,J.HERSON,J.IULIUCCI,M.WEIGELE,T.SAWYER
JRNL TITL STRUCTURE-BASED DESIGN OF AN OSTEOCLAST-SELECTIVE,
JRNL TITL 2 NONPEPTIDE SRC HOMOLOGY 2 INHIBITOR WITH IN VIVO
JRNL TITL 3 ANTIRESORPTIVE ACTIVITY.
JRNL REF PROC.NATL.ACAD.SCI.USA V. 97 9373 2000
JRNL REFN ISSN 0027-8424
JRNL PMID 10944210
JRNL DOI 10.1073/PNAS.97.17.9373
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 88.3
REMARK 3 NUMBER OF REFLECTIONS : 9476
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : NULL
REMARK 3 R VALUE (WORKING SET) : 0.230
REMARK 3 FREE R VALUE : 0.360
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL
REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL
REMARK 3 BIN R VALUE (WORKING SET) : NULL
REMARK 3 BIN FREE R VALUE : NULL
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1668
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 90
REMARK 3 SOLVENT ATOMS : 40
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : NULL
REMARK 3 BOND ANGLES (DEGREES) : NULL
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1FBZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-JUL-00.
REMARK 100 THE DEPOSITION ID IS D_1000011466.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 29-OCT-98
REMARK 200 TEMPERATURE (KELVIN) : 113.0
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : GRAPHITE
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9476
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400
REMARK 200 RESOLUTION RANGE LOW (A) : 15.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 88.3
REMARK 200 DATA REDUNDANCY : 6.000
REMARK 200 R MERGE (I) : 0.09000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 54.91
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.73
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.43500
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.38500
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.13000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.38500
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.43500
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.13000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 GLU A 1 CG CD OE1 OE2
REMARK 470 GLU B 201 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 HG1 THR B 225 HH21 ARG B 300 1.16
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 HE22 GLN A 18 H ASP B 265 4566 1.22
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 22 146.59 -39.10
REMARK 500 THR A 25 -162.06 -160.20
REMARK 500 GLU A 35 -67.33 -90.83
REMARK 500 THR A 37 -164.70 -118.76
REMARK 500 GLN A 50 -38.44 -28.55
REMARK 500 ASN A 51 -79.30 -70.08
REMARK 500 TYR A 70 138.10 -179.15
REMARK 500 PRO A 73 1.77 -62.27
REMARK 500 SER A 99 -73.59 -58.00
REMARK 500 LYS B 208 -84.37 1.17
REMARK 500 THR B 237 -179.58 -170.06
REMARK 500 ASP B 247 -156.24 -148.95
REMARK 500 GLN B 252 -104.33 -83.76
REMARK 500 ASN B 263 -168.41 -105.64
REMARK 500 ALA B 290 132.57 -178.64
REMARK 500 SER B 299 -101.72 -69.53
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CC1 A 150
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CC1 B 350
DBREF 1FBZ A 1 104 UNP P06239 LCK_HUMAN 123 226
DBREF 1FBZ B 201 304 UNP P06239 LCK_HUMAN 123 226
SEQADV 1FBZ CYS A 42 UNP P06239 SER 164 CONFLICT
SEQADV 1FBZ CYS B 242 UNP P06239 SER 164 CONFLICT
SEQRES 1 A 104 GLU PRO GLU PRO TRP PHE PHE LYS ASN LEU SER ARG LYS
SEQRES 2 A 104 ASP ALA GLU ARG GLN LEU LEU ALA PRO GLY ASN THR HIS
SEQRES 3 A 104 GLY SER PHE LEU ILE ARG GLU SER GLU SER THR ALA GLY
SEQRES 4 A 104 SER PHE CYS LEU SER VAL ARG ASP PHE ASP GLN ASN GLN
SEQRES 5 A 104 GLY GLU VAL VAL LYS HIS TYR LYS ILE ARG ASN LEU ASP
SEQRES 6 A 104 ASN GLY GLY PHE TYR ILE SER PRO ARG ILE THR PHE PRO
SEQRES 7 A 104 GLY LEU HIS GLU LEU VAL ARG HIS TYR THR ASN ALA SER
SEQRES 8 A 104 ASP GLY LEU CYS THR ARG LEU SER ARG PRO CYS GLN THR
SEQRES 1 B 104 GLU PRO GLU PRO TRP PHE PHE LYS ASN LEU SER ARG LYS
SEQRES 2 B 104 ASP ALA GLU ARG GLN LEU LEU ALA PRO GLY ASN THR HIS
SEQRES 3 B 104 GLY SER PHE LEU ILE ARG GLU SER GLU SER THR ALA GLY
SEQRES 4 B 104 SER PHE CYS LEU SER VAL ARG ASP PHE ASP GLN ASN GLN
SEQRES 5 B 104 GLY GLU VAL VAL LYS HIS TYR LYS ILE ARG ASN LEU ASP
SEQRES 6 B 104 ASN GLY GLY PHE TYR ILE SER PRO ARG ILE THR PHE PRO
SEQRES 7 B 104 GLY LEU HIS GLU LEU VAL ARG HIS TYR THR ASN ALA SER
SEQRES 8 B 104 ASP GLY LEU CYS THR ARG LEU SER ARG PRO CYS GLN THR
HET CC1 A 150 45
HET CC1 B 350 45
HETNAM CC1 {4-[2-ACETYLAMINO-2-(3-CARBAMOYL-2-CYCLOHEXYLMETHOXY-6,
HETNAM 2 CC1 7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5YLCARBAMOYL)-
HETNAM 3 CC1 ETHYL]-2-PHOSPHONO-PHENYL}-PHOSPHONIC ACID
FORMUL 3 CC1 2(C30 H41 N3 O10 P2)
FORMUL 5 HOH *40(H2 O)
HELIX 1 1 SER A 11 LEU A 20 1 10
HELIX 2 2 GLY A 79 ALA A 90 1 12
HELIX 3 3 SER B 211 ALA B 221 1 11
HELIX 4 4 GLY B 279 ALA B 290 1 12
SHEET 1 A 4 PHE A 29 GLU A 33 0
SHEET 2 A 4 PHE A 41 ASP A 47 -1 N CYS A 42 O ARG A 32
SHEET 3 A 4 VAL A 55 ASN A 63 -1 N VAL A 55 O ASP A 47
SHEET 4 A 4 PHE A 69 TYR A 70 -1 O TYR A 70 N ARG A 62
SHEET 1 B 5 PHE B 206 PHE B 207 0
SHEET 2 B 5 PHE B 229 GLU B 233 1 O ILE B 231 N PHE B 207
SHEET 3 B 5 PHE B 241 ARG B 246 -1 N CYS B 242 O ARG B 232
SHEET 4 B 5 VAL B 256 ASN B 263 -1 O LYS B 257 N VAL B 245
SHEET 5 B 5 PHE B 269 TYR B 270 -1 O TYR B 270 N ARG B 262
SITE 1 AC1 14 ARG A 12 ARG A 32 GLU A 35 SER A 36
SITE 2 AC1 14 HIS A 58 TYR A 59 LYS A 60 ILE A 71
SITE 3 AC1 14 SER A 72 GLY A 93 ARG B 217 ARG B 285
SITE 4 AC1 14 HIS B 286 ASN B 289
SITE 1 AC2 15 GLU A 1 ARG B 212 ARG B 232 SER B 234
SITE 2 AC2 15 GLU B 235 SER B 236 CYS B 242 HIS B 258
SITE 3 AC2 15 TYR B 259 LYS B 260 ARG B 262 SER B 272
SITE 4 AC2 15 ASP B 292 GLY B 293 LEU B 294
CRYST1 44.870 56.260 102.770 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022287 0.000000 0.000000 0.00000
SCALE2 0.000000 0.017775 0.000000 0.00000
SCALE3 0.000000 0.000000 0.009730 0.00000